IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 109 filers reported holding IGM BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50 | -67.3% | 6,303 | -30.7% | 0.00% | – |
| Q1 2023 | $153 | +4.1% | 9,100 | 0.0% | 0.00% | – |
| Q4 2022 | $147 | -99.9% | 9,100 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $176,000 | +6.7% | 9,100 | 0.0% | 0.00% | – |
| Q2 2022 | $165,000 | -29.8% | 9,100 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $235,000 | -2.5% | 9,100 | +9.6% | 0.00% | 0.0% |
| Q4 2021 | $241,000 | -54.5% | 8,300 | +2.5% | 0.00% | 0.0% |
| Q3 2021 | $530,000 | -20.7% | 8,100 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $668,000 | +11.3% | 8,100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $600,000 | -15.1% | 8,100 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $707,000 | – | 8,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,425,455 | $252,833,000 | 4.64% |
| Ikarian Capital, LLC | 313,300 | $23,124,000 | 1.67% |
| Ikarian Capital, LLC | 250,000 | $18,452,000 | 1.34% |
| RA Capital Management | 982,723 | $72,535,000 | 1.33% |
| Artal Group S.A. | 688,910 | $50,848,000 | 1.23% |
| Baker Brothers Advisors | 3,144,446 | $232,092,000 | 0.93% |
| Cormorant Asset Management, LP | 225,000 | $16,607,000 | 0.64% |
| MOODY ALDRICH PARTNERS LLC | 37,737 | $2,785,000 | 0.58% |
| HighVista Strategies LLC | 9,417 | $695,000 | 0.51% |
| Vivo Capital, LLC | 103,480 | $7,638,000 | 0.44% |